Description

Simple

Clinical

Overview

ACP-HIP is a natural compound with potential activity against the causative viral agent of Kaposi's sarcoma. It is a novel protein extracted from pregnancy usrine. ACP-HIP has the potential to be of benefit in the currently unmet need for treatment and control of Kaposi's sarcoma, a malignancy associated with severe immunosuppression observed in AIDS patients.

Pharmacology

Indication

Investigated for use/treatment in kaposi's sarcoma.

Pharmacodynamic

ACP-HIP, now in clinical trials, has been found to inhibit the proliferation of AIDS-causing HIV cells, and to inhibit the
spread of Kaposi’s sarcoma, an AIDS-relat-ed cancer. Preclinical studies show that ACP-HIP have led to the inhibition os HIV cell growth and ubduction of KS cell death. This dr... Read more

Mechanism of action

ACP-HIP inhibits the growth of Kaposi's sarcoma cells and kills HIV through a mechanism different from that used by commercially available drugs. ACP-HIP stops replication of KS, therefore lowering overall viral burden and eliminating
further progress of virus.

Absorption

Information currently not available.

Protein binding

Information currently not available.

Volume of distribution

Information currently not available.

Clearance

Information currently not available.

Half life

Information currently not available.

Route of elimination

Information currently not available.

Toxicity

Information currently not available.

Adverse Effects

Contraindications

Information currently not available.

Food Interactions

    Information currently not available.

Interactions

Type in a drug name to check for interaction with ACP-HIP
Type a drug name in the box above to get started
  • Paracetamol(acetaminophen)
  • Paxil(paroxetine)
  • Pamelor(nortriptyline)
  • Panadol(acetaminophen)
  • Patanol(olopatadine ophthalmic)
  • Pataday(olopatadine ophthalmic)
  • Parnate(tranylcypromine)
  • Pazeo(olopatadine ophthalmic)